totally agree, there's no hope for dendreon. xtandi is growing sales in post-chemo and has already surpassed provenge on revenues. with EU sales, they will reach $100M a quarter probably before christmas. add japan, brazil, and other countries coming online... $125M a quarter in early 2014.
fools here refused to listen to folks like you (stoploss) and instead focused blindly on "we're gonna beat last quarter's sales".
Johnson has no EU partner willing to give them money... only rent them sales staff.
with CFO resigning, i'd bet the dilution occurs very soon. the longer they wait, the lower share price will drift and the more shares they will be forced to issue. definitely a $2 stock here...